A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Dermavant Sciences, Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT05789576
- Locations
- 🇺🇸
Dermavant Investigative Sites, Rockville, Maryland, United States
🇺🇸Dermavant Investigative Site, Arlington, Texas, United States
A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis
- First Posted Date
- 2023-01-11
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Dermavant Sciences, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT05680740
- Locations
- 🇺🇸
Dermavant Investigative Site, Webster, Texas, United States
Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Dermavant Sciences, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05186805
- Locations
- 🇨🇦
Dermavant Investigative Site, Calgary, Alberta, Canada
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Dermavant Sciences, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05172726
- Locations
- 🇨🇦
Dermavant Clinical Trials, Oshawa, Ontario, Canada
🇨🇦Dermavant Clinical Site, Montréal, Quebec, Canada
Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis
- First Posted Date
- 2021-12-03
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Dermavant Sciences, Inc.
- Target Recruit Count
- 728
- Registration Number
- NCT05142774
- Locations
- 🇺🇸
Dermavant lnvestigative Site, Greenville, South Carolina, United States
🇨🇦Dermavant Investigative Site, Montréal, Quebec, Canada
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)
Phase 3
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: vehicle cream
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Dermavant Sciences, Inc.
- Target Recruit Count
- 406
- Registration Number
- NCT05032859
- Locations
- 🇺🇸
Dermanvant Investigative Site, Brooklyn, New York, United States
🇨🇦Dermavant Investigative Site, Windsor, Ontario, Canada
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults
Phase 3
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Vehicle cream
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Dermavant Sciences, Inc.
- Target Recruit Count
- 407
- Registration Number
- NCT05014568
- Locations
- 🇨🇦
Dermavant Investigative Site, Montréal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath